	2012 Mar 31	R 2013 Mar 31	C 2014 Mar 31	2015 Mar 31	2016 Mar 31	R 2017 Mar 31	2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31

Period length: Source:	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR
Total Revenue	179.57	203.03	235.59	260.55	279.37	287.43	332.68	318.97	243.64	248.45	247.63	278.99	331.69	402.32	473.07
Cost of Operating Revenue	-	-	4.28	6.45	5.49	4.57	4.38	4.58	9.10	8.74	8.51	11.68	11.65	12.99	-
Gross Profit	179.57	203.03	231.31	254.09	273.87	282.86	328.30	314.39	234.55	239.71	239.12	267.31	320.04	389.32	473.07
Gross Margin	100.0	100.0	98.2	97.5	98.0	98.4	98.7	98.6	96.3	96.5	96.6	95.8	96.5	96.8	100.0
Total Operating Expenses	58.29	71.55	90.76	106.05	109.66	108.48	124.96	147.63	170.09	160.48	175.52	184.48	230.03	258.70	290.05
Operating Profit	121.28	131.48	144.83	154.50	169.71	178.96	207.73	171.34	73.55	87.97	72.12	94.52	101.66	143.62	183.02
Operating Margin	67.5	64.8	61.5	59.3	60.7	62.3	62.4	53.7	30.2	35.4	29.1	33.9	30.6	35.7	38.7
Financing Income/(Expense) - Net	28.19	28.65	35.73	42.13	8.34	18.96	18.86	15.04	11.86	15.99	25.02	35.48	41.33	43.82	47.32
Profit before Taxes	149.60	160.22	180.57	196.87	178.39	212.49	233.08	201.73	104.09	118.65	98.63	125.75	146.63	192.27	235.35
Income Taxes	41.97	46.55	50.92	59.05	58.79	64.87	70.74	63.66	20.61	27.68	21.80	40.29	44.07	52.26	61.66
Profit after Tax	107.61	113.58	129.41	137.82	119.60	147.64	162.41	137.47	82.37	89.52	75.11	83.53	100.52	137.24	171.18
PAT Margin	59.9	55.9	54.9	52.9	42.8	51.4	48.8	43.1	33.8	36.0	30.3	29.9	30.3	34.1	36.2
EPS - Basic - ex Extraordinary Items	37.69	39.78	44.96	47.53	41.14	50.17	54.57	46.66	27.96	30.38	25.45	28.17	33.77	45.89	57.06
EPS - Diluted - ex Extraordinary Items	37.69	39.78	44.94	47.08	40.88	50.14	54.56	46.66	27.96	30.33	25.31	28.17	33.67	45.69	56.83
EBIT	121.28	131.48	144.83	154.50	169.71	178.96	207.73	171.34	73.55	87.97	72.12	94.52	101.66	143.62	183.02
EBITDA	125.57	134.73	147.75	159.59	173.88	182.35	210.88	174.67	81.32	95.77	79.82	105.05	112.14	155.34	197.40
EBITDA Margin	69.9	66.4	62.7	61.3	62.2	63.4	63.4	54.8	33.4	38.5	32.2	37.7	33.8	38.6	41.7

Balance Sheet

Abridged

Understanding Balance Sheet

Care Ratings Ltd. balance sheet covering assets, liabilities, equity and borrowings across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2012 Mar 31	R 2013 Mar 31	C 2014 Mar 31	2015 Mar 31	R 2016 Mar 31	R 2017 Mar 31	2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	R 2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31

Source:	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR
Total Current Assets	157	295	319	184	236	440	341	279	296	547	564	602	675	692	677
Long-Term Investments	52	143	191	186	234	81	255	249	226	34	55	54	50	139	297
Property Plant & Equipment - Net	48	51	52	57	55	53	51	74	84	77	87	97	98	102	104
Total Non-Current Assets	265	213	262	262	300	145	318	336	323	125	163	168	167	266	427
Total Assets	430	508	581	445	536	585	659	615	619	672	727	770	842	958	1,105
Total Current Liabilities	46	75	87	78	50	49	50	49	60	53	51	58	79	98	118
Long Term Debt	-	-	-	-	-	-	-	-	8	4	6	15	17	20	22
Total Non-Current Liabilities	6	8	8	8	16	15	10	14	23	26	23	33	38	44	44
Total Liabilities	52	83	95	87	66	64	60	63	83	79	75	91	117	142	162
Total Shareholders' Equity	377	424	485	359	470	520	597	550	533	589	647	672	717	806	932
Minority Interest	1	1	1	-	-	0	2	2	3	4	5	7	7	9	11
Total Equity	378	425	486	359	470	521	599	552	537	593	653	679	725	816	943
Total Liabilities & Equity	430	508	581	445	536	585	659	615	619	672	727	770	842	958	1,105

Cash Flow

Abridged

Understanding Cash Flow Statement

Care Ratings Ltd. cash flow statement covering operating, investing and financing activities across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	C 2012 Mar 31	R 2013 Mar 31	R 2014 Mar 31	2015 Mar 31	2016 Mar 31	C 2017 Mar 31	R 2018 Mar 31	2019 Mar 31	C 2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31

Period length: Source:	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR
Operating CF bef Changes in Working Cap	98	94	102	112	120	119	155	123	63	73	89	96	116	157	238
Working Capital - Increase/(Decrease)	0	-11	5	-6	-13	0	-21	-15	4	13	4	4	13	12	13
Net CF from Operating Activities	98	83	107	106	106	119	134	109	66	86	93	100	129	169	250
Capital Expenditures - Net	8	6	3	11	3	1	2	26	4	4	19	11	9	15	8
Net CF from Investing Activities	-7	-87	-46	157	-41	-22	-25	83	27	-38	-52	-6	-79	-107	-200
Dividends Paid - Cash - Total	40	40	95	275	91	99	99	195	103	40	38	60	67	55	58
Stock - Issuance/(Retirement) - Net	-	-	25	-	25	3	1	-	-	-	6	2	8	4	7
Debt - LT & ST - Issuance/(Retirement) - Total	-	-	-	-	-	-	-	-	-3	-3	-3	-3	-2	-1	-5
Net Cash Flow from Financing Activities	-40	-40	-62	-275	-66	-96	-99	-195	-106	-43	-35	-62	-61	-52	-57
Free Cash Flow to Equity	90	77	104	95	104	118	131	82	59	78	71	85	118	153	237
Free Operating CF net dividend	49	37	9	-180	12	19	32	-113	-41	41	35	29	53	99	183
Free Operating CF	90	77	104	95	104	118	131	82	62	81	74	88	120	154	242

Business Segment Analysis

FY End:

Mar 25

Care Ratings Ltd. business segment breakdown covering revenue, operating income and assets across key divisions for the selected financial year.

Revenue / Sales

Ratings and related services (89.4%)₹ 360.12 CrOthers (10.6%)₹ 42.57 Cr

Assets

Ratings and related services (80.4%)₹ 770.49 CrUnallocated (14.8%)₹ 142.02 CrOthers (4.7%)₹ 45.23 Cr

Regional Segment Analysis

Care Ratings Ltd. geographic revenue split showing domestic and international market performance across revenue and income for the selected financial year.

We don't have enough data to show regional segment analysis for Care Ratings Ltd.

Historical Segment Analysis

Track how Care Ratings Ltd. segment contributions have evolved over multiple financial years to see which divisions are growing, shrinking or gaining strategic importance.

Capex

Sales

Assets

Operating Income

Business

Regional

Business

	2017 Mar 31	2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31

Others	0	0	1	1	0
Ratings and related services	1	2	26	4	5

Frequently Asked Questions

What is the revenue of Care Ratings Ltd.?

The latest trailing twelve month revenue of Care Ratings Ltd. is ₹ 473.07 Cr, reflecting a 1-year growth of 17.59% and a 3-year CAGR of 19.25%. Annual and quarterly revenue trends are available in the Income Statement section.

What is the net profit of Care Ratings Ltd.?

The latest trailing twelve month net profit (PAT) of Care Ratings Ltd. is ₹ 171.18 Cr, with a 3-year earnings CAGR of 26.36%. Detailed profit history across annual and quarterly periods is in the Income Statement section.

What is the EBITDA of Care Ratings Ltd.?

The trailing twelve month EBITDA of Care Ratings Ltd. is approximately ₹ 183.03 Cr (based on an operating margin of 38.69%). EBITDA reflects core operating profitability before interest, taxes, depreciation and amortisation.

What is the EPS of Care Ratings Ltd.?

The trailing twelve month Earnings Per Share (EPS) of Care Ratings Ltd. is 56.83. EPS trends across annual and quarterly periods are visible in the Income Statement section.

What is the debt level of Care Ratings Ltd.?

The debt-to-equity ratio of Care Ratings Ltd. stands at 0.03. The interest coverage ratio is 73.62x, reflecting the company's ability to service debt from operating earnings. The full breakdown of total borrowings is in the Balance Sheet section.

What is the book value per share of Care Ratings Ltd.?

The estimated book value per share of Care Ratings Ltd. is 309.92 (derived from a P/B ratio of 5.19 and market price of ₹ 1,610.00), reflecting the net asset value attributable to each share. See the Balance Sheet section for a full breakdown.

What is the cash flow from operations of Care Ratings Ltd.?

The trailing twelve month operating cash flow of Care Ratings Ltd. is ₹ 250.15 Cr. Annual and quarterly cash flow data is available in the Cash Flow section of the Statements tab.

Does Care Ratings Ltd. report consolidated or standalone financials?

Care Ratings Ltd. reports consolidated financials. You can toggle between consolidated and standalone views using the switch at the top of each statement section.